Kim Jin Yong, Om Sang Yong, Shin Su-Jin, Kim Jeong Eun, Yoon Dok Hyun, Suh Cheolwon
Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Blood Res. 2014 Dec;49(4):270-4. doi: 10.5045/br.2014.49.4.270. Epub 2014 Dec 23.
Precursor B-cell lymphoblastic lymphoma (B-LBL) is an uncommon subtype of Non-Hodgkin lymphoma (NHL), accounting for only 0.3% of NHL in adults and less than 10% of all LBL cases. Unlike T-cell LBL, it usually presents with extranodal involvement while sparing the bone marrow (BM). Among the 27 patients with LBL treated in the Asan Medical Center between January 2007 and March 2012, 3 had B-LBL. All had a good performance status and low International Prognostic Index. However, unlike most previously reported cases, the patients had lymphoma in their bone marrow and extranodal sites such as bone and lung. After intensive combination chemotherapy, one patient achieved a complete response and the other 2 patients, a partial response. Our experience suggests that multiple extranodal sites may be involved in B-LBL and BM involvement may not be as infrequent as previously thought. Furthermore, intensive chemotherapy seems to be effective.
前驱B细胞淋巴母细胞淋巴瘤(B-LBL)是非霍奇金淋巴瘤(NHL)中一种罕见的亚型,仅占成人NHL的0.3%,在所有淋巴母细胞淋巴瘤(LBL)病例中占比不到10%。与T细胞LBL不同,它通常表现为结外受累,而不累及骨髓(BM)。在2007年1月至2012年3月于峨山医学中心接受治疗的27例LBL患者中,有3例为B-LBL。所有患者的体能状态良好且国际预后指数较低。然而,与大多数先前报道的病例不同,这些患者的骨髓以及骨和肺等结外部位都出现了淋巴瘤。经过强化联合化疗后,1例患者达到完全缓解,另外2例患者达到部分缓解。我们的经验表明,B-LBL可能累及多个结外部位,且骨髓受累可能并不像先前认为的那样罕见。此外,强化化疗似乎是有效的。